|
| General Information | |||
|---|---|---|---|
| Term | glucocorticoid-remediable aldosteronism | ID (Ontology) | DOID:14080 (Human Disease) |
| Definition | A primary hyperaldosteronism characterized by variably expressed and severe hypertension, hyperaldosteronism and abnormal adrenal steroid production which improve with exogenous glucocorticoid administration that has_material_basis_in a chimeric gene formed of the CYP11B2 and CYP11B1 genes on chromosome 8q24.3. | ||
| Also Known As | "familial hyperaldosteronism type I" ; "glucocorticoid-suppressible hyperaldosteronism" ; "GRA" (for all, see Synonyms field below) | ||
| Comment | |||
| Links to External Ontologies | |||
| DO.org | |||
| Annotations | |||
| Records annotated with this term OR any of its CHILD TERMS | |||
Full annotation statements including this term (annotations to child terms are NOT included), and relevant FlyBase records
|
|||
|
||||||
adrenal gland hyperfunction |__primary hyperaldosteronism |__glucocorticoid-remediable aldosteronism 12 rec. |
| Spanning Tree View Settings | |||
|---|---|---|---|
| Parents/Children View Depth |
|||
Relationships
|
|||
| Is a | primary hyperaldosteronism | ||
| Part of | |||
|
Synonyms & Secondary IDs
|
|||
| Synonyms | |||
|
|||
| Secondary IDs | |||
|
|
|||
|
External Crossreferences & Linkouts
|
|||
|
GARD:2790 ICD10CM:E26.02 ICD9CM:255.11 MESH:C563177 MIM:103900 NCI:C127161 SNOMEDCT_US_2023_03_01:703232003 UMLS_CUI:C3838731 |
|||